Heparin Sodium and Sodium Chloride (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Heparin Sodium and Sodium Chloride drug offered from Baxter Healthcare Corporation. This Anti-coagulant [EPC],Heparin [Chemical/Ingredient],Unfractionated Heparin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | HEPARIN SODIUM |
SUBSTANCE NAME: | HEPARIN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-coagulant [EPC],Heparin [Chemical/Ingredient],Unfractionated Heparin [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1982-04-28 |
END MARKETING DATE: | 0000-00-00 |
Heparin Sodium and Sodium Chloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Heparin Sodium and Sodium Chloride from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200([USP’U]/100mL) |
START MARKETING DATE: | 1982-04-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0338-0431_9930df8e-e1d7-495f-8f68-9a96604164f5 |
PRODUCT NDC: | 0338-0431 |
APPLICATION NUMBER: | NDA018609 |
Other HEPARIN SODIUM Pharmaceutical Manufacturers / Labelers: